Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Guardant Health (GH) PT Raised to $60 at Leerink Partners

November 7, 2024 5:56 AM EST

Leerink Partners analyst Puneet Souda raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $50.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: GH addressed two major questions weighing on the shares heading into the quarter: (1) slowdown in its... More